¼¼°èÀÇ ¼ö¸é º¸Á¶Á¦ ½ÃÀå º¸°í¼­(2025³â)
Sleeping Aids Global Market Report 2025
»óǰÄÚµå : 1821652
¸®¼­Ä¡»ç : The Business Research Company
¹ßÇàÀÏ : On Demand Report
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 250 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,490 £Ü 6,457,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,490 £Ü 9,334,000
PDF (Site License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷ÀåÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,490 £Ü 12,211,000
PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
¤± º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼Û±âÀÏÀº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¼ö¸é º¸Á¶Á¦ ½ÃÀå ±Ô¸ð´Â ÇâÈÄ ¼ö³â°£ °­·ÂÇÑ ¼ºÀåÀÌ ¿¹»óµË´Ï´Ù. 2029³â ¿¬Æò±Õ ¼ºÀå·ü(CAGR)Àº 8.8%¸¦ ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹ÃøµÇ°í 1,326¾ï 9,000¸¸ ´Þ·¯·Î ¼ºÀåÇÒ Àü¸ÁÀÔ´Ï´Ù. ¿¹Ãø ±â°£ µ¿¾ÈÀÇ ¼ºÀåÀº À£ºù ¹× Àڱ⠰ü¸® Æ®·»µå, Á¤½Å °Ç°­ ÀνÄ, °¡Á¤ ±â¹Ý ¼ö¸é ¼Ö·ç¼Ç, ¸ÂÃãÇü ¼ö¸é ¼Ö·ç¼Ç, ÀÚ¿¬ÀûÀÌ°í ºñħ½ÀÀûÀÎ ¿É¼Ç µî¿¡ ±âÀÎÇÒ ¼ö ÀÖ½À´Ï´Ù. ¿¹Ãø ±â°£ÀÇ ÁÖ¿ä µ¿Çâ¿¡´Â À£ºù ¹× Àڱ⠰ü¸® °­Á¶, ±â¼ú ÅëÇÕ, ¼ö¸é À§»ý ±³À°, ¾ÈÀü¿¡ ÁÖ·ÂÇÏ´Â ±ÔÁ¦°¡ Æ÷ÇԵ˴ϴÙ.

ÇâÈÄ 5³â°£ 8.8% ¼ºÀå ¿¹ÃøÀº ÀÌ ½ÃÀå¿¡ ´ëÇÑ ÀÌÀü ÃßÁ¤Ä¡ ´ëºñ 0.3% ¼ÒÆø Ç϶ôÇÑ ¼öÄ¡ÀÔ´Ï´Ù. ÀÌ Ç϶ôÀº ÁÖ·Î ¹Ì±¹°ú Ÿ±¹ °£ °ü¼¼ ¿µÇâ ¶§¹®ÀÔ´Ï´Ù. °ü¼¼ À庮Àº Àεµ¿Í ij³ª´Ù¿¡¼­ ¿ø»êµÇ´Â ó¹æ µî±Þ ¸á¶óÅä´Ñ ¹× ºñº¥Á¶µð¾ÆÁ¦Çɰè ÁøÁ¤Á¦ÀÇ ºñ¿ëÀ» Áõ°¡½ÃÄÑ ¹Ì±¹ ½ÃÀå¿¡ ºÎÁ¤Àû ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ´Â ºÒ¸éÁõ ȯÀÚÀÇ Ä¡·á ¼øÀÀµµ¸¦ °¨ÃàÇϰí Á¤½Å °Ç°­ ¼­ºñ½º ºñ¿ëÀ» »ó½Â½Ãų °ÍÀÔ´Ï´Ù. ¶ÇÇÑ »óÈ£ °ü¼¼ ºÎ°ú¿Í ¹«¿ª ±äÀå ¹× Á¦ÇÑ °­È­·Î ÀÎÇÑ Àü ¼¼°è °æÁ¦ ¹× ¹«¿ª¿¡ ´ëÇÑ ºÎÁ¤Àû ¿µÇâÀ¸·Î ±× È¿°ú°¡ ´õ ±¤¹üÀ§ÇÏ°Ô ³ªÅ¸³¯ °ÍÀÔ´Ï´Ù.

¼ö¸é º¸Á¶Á¦ ½ÃÀåÀÇ ¼ºÀå ±ËÀûÀº ¼ö¸é Àå¾Ö ¹ß»ý·ü Áõ°¡¿¡ »ó´çÇÑ ¿µÇâÀ» ¹ÞÀ» °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¼ö¸é ºÎÁ·¿¡¼­ ºñ·ÔµÈ ¼ö¸é Àå¾Ö´Â Àü¹ÝÀûÀÎ °Ç°­¿¡ Áß´ëÇÑ ¿µÇâÀ» ¹ÌĨ´Ï´Ù. ¼ö¸é º¸Á¶Á¦´Â ¼ö¸é ºÎÁ·À¸·Î ÀÎÇÑ ÀÎÁö ±â´É ÀúÇϸ¦ ¿ÏÈ­ÇÒ »Ó¸¸ ¾Æ´Ï¶ó ¼ö¸éÀÇ ÁúÀ» ´Ü±âÀûÀ¸·Î ÃËÁøÇÏ´Â µ¥ Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. ƯÈ÷ 2022³â 1¿ù ±âÁØ, ±¹¸³»ý¹°°øÇÐÁ¤º¸¼¾ÅÍ(NCBI) ÀÚ·á¿¡ µû¸£¸é ´Ù¾çÇÑ Áý´Ü¿¡¼­ ¼ö¸é ¹®Á¦ À¯º´·üÀÌ È®ÀεǾúÀ¸¸ç, Äڷγª19 ȯÀÚÀÇ °æ¿ì 52.39%, ¾Æµ¿ ¹× û¼Ò³â 45.96%, ÀÇ·á Á¾»çÀÚ 42.47%, ÀÇ·áÀû Çʿ䰡 Àִ Ư¼ö Áý´Ü 41.50%, ´ëÇлý 41.16%, ÀÏ¹Ý Àα¸ 36.73%·Î ³ªÅ¸³µ½À´Ï´Ù. ÀÌó·³ ¼ö¸é Àå¾Ö°¡ Áõ°¡ÇÏ´Â Çö»óÀº ¼ö¸é º¸Á¶Á¦¿¡ ´ëÇÑ ¼ö¿ä°¡ ³ô¾ÆÁö°í ÀÖÀ½À» º¸¿©ÁÖ¸ç, À̸¦ ÇʼöÀûÀÎ ÇØ°áÃ¥À¸·Î ÀÚ¸®¸Å±èÇÏ°Ô ÇÕ´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ½ÃÀå Æ¯Â¡

Á¦3Àå ½ÃÀå µ¿Çâ°ú Àü·«

Á¦4Àå ½ÃÀå : ±Ý¸®, ÀÎÇ÷¹À̼Ç, ÁöÁ¤ÇÐ, ¹«¿ªÀüÀï°ú °ü¼¼, ±×¸®°í Äڷγª ¹× ȸº¹ÀÌ ½ÃÀå¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» Æ÷ÇÔÇÑ °Å½Ã°æÁ¦ ½Ã³ª¸®¿À

Á¦5Àå ¼¼°èÀÇ ¼ºÀå ºÐ¼®°ú Àü·« ºÐ¼® ÇÁ·¹ÀÓ¿öÅ©

Á¦6Àå ½ÃÀå ¼¼ºÐÈ­

Á¦7Àå Áö¿ªº° ¹× ±¹°¡º° ºÐ¼®

Á¦8Àå ¾Æ½Ã¾ÆÅÂÆò¾ç ½ÃÀå

Á¦9Àå Áß±¹ ½ÃÀå

Á¦10Àå Àεµ ½ÃÀå

Á¦11Àå ÀϺ» ½ÃÀå

Á¦12Àå È£ÁÖ ½ÃÀå

Á¦13Àå Àεµ³×½Ã¾Æ ½ÃÀå

Á¦14Àå Çѱ¹ ½ÃÀå

Á¦15Àå ¼­À¯·´ ½ÃÀå

Á¦16Àå ¿µ±¹ ½ÃÀå

Á¦17Àå µ¶ÀÏ ½ÃÀå

Á¦18Àå ÇÁ¶û½º ½ÃÀå

Á¦19Àå ÀÌÅ»¸®¾Æ ½ÃÀå

Á¦20Àå ½ºÆäÀÎ ½ÃÀå

Á¦21Àå µ¿À¯·´ ½ÃÀå

Á¦22Àå ·¯½Ã¾Æ ½ÃÀå

Á¦23Àå ºÏ¹Ì ½ÃÀå

Á¦24Àå ¹Ì±¹ ½ÃÀå

Á¦25Àå ij³ª´Ù ½ÃÀå

Á¦26Àå ³²¹Ì ½ÃÀå

Á¦27Àå ºê¶óÁú ½ÃÀå

Á¦28Àå Áßµ¿ ½ÃÀå

Á¦29Àå ¾ÆÇÁ¸®Ä« ½ÃÀå

Á¦30Àå °æÀï ±¸µµ¿Í ±â¾÷ ÇÁ·ÎÆÄÀÏ

Á¦31Àå ±âŸ ÁÖ¿ä ±â¾÷ ¹× Çõ½Å ±â¾÷

Á¦32Àå ¼¼°è ½ÃÀå °æÀï º¥Ä¡¸¶Å·°ú ´ë½Ãº¸µå

Á¦33Àå ÁÖ¿ä ÀμöÇÕº´(M&A)

Á¦34Àå ÃÖ±Ù ½ÃÀå µ¿Çâ

Á¦35Àå ½ÃÀåÀÇ ÀáÀç·ÂÀÌ ³ôÀº ±¹°¡, ºÎ¹®, Àü·«

Á¦36Àå ºÎ·Ï

HBR
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The term 'sleeping aids' encompasses a range of psychoactive medications aimed at addressing insomnia and occasional sleep disturbances. These aids are designed to alleviate daytime fatigue and cognitive impairment caused by sleep disruptions.

Different categories of sleeping aids include mattresses, pillows, sleep laboratories, medications (both prescription and over-the-counter), herbal remedies, and devices for conditions like sleep apnea. 'Medications' encompass formulations comprising various active and inactive ingredients tailored to address specific sleep-related issues such as insomnia, sleep deprivation, narcolepsy, and sleep apnea. These aids are commonly available through hospital pharmacies, retail outlets, online platforms, drug stores, and similar channels.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The sleeping aids market research report is one of a series of new reports from The Business Research Company that provides sleeping aids market statistics, including sleeping aids industry global market size, regional shares, competitors with a sleeping aids market share, detailed sleeping aids market segments, market trends and opportunities, and any further data you may need to thrive in the sleeping aids industry. This sleeping aids market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The sleeping aids market size has grown strongly in recent years. It will grow from $89.05 billion in 2024 to $94.85 billion in 2025 at a compound annual growth rate (CAGR) of 6.5%. The growth in the historic period can be attributed to increased stress and sleep disorders, aging population, lifestyle changes, awareness and education, consumer preference for natural remedies.

The sleeping aids market size is expected to see strong growth in the next few years. It will grow to $132.69 billion in 2029 at a compound annual growth rate (CAGR) of 8.8%. The growth in the forecast period can be attributed to wellness and self-care trends, mental health awareness, home-based sleep solutions, personalized sleep solutions, natural and non-invasive options. Major trends in the forecast period include wellness and self-care emphasis, technological integration, sleep hygiene education, regulatory focus on safety.

The forecast of 8.8% growth over the next five years reflects a modest reduction of 0.3% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff barriers are expected to hamper the U.S. by increasing the cost of prescription-grade melatonin and non-benzodiazepine sedatives sourced from India and Canada, thereby reducing treatment adherence for insomnia patients and elevating mental health service costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The growth trajectory of the sleeping aids market is expected to be significantly influenced by the increasing incidence of sleep disorders. Sleep disorders, stemming from insufficient sleep, have substantial implications for overall health. Sleeping aids play a crucial role as medications, not only in mitigating cognitive impairment resulting from sleep deprivation but also in promoting short-term improvements in sleep quality. Notably, as of January 2022, data from the National Center for Biotechnology Information reveals the prevalence of sleep problems in diverse populations, with rates projected at 52.39% for COVID-19 patients, 45.96% for children and adolescents, 42.47% for healthcare workers, 41.50% for special populations with healthcare needs, 41.16% for university students, and 36.73% for the general population. This observed rise in sleep disorders underscores the increasing demand for sleeping aids, positioning them as essential solutions.

The rising global aging population is anticipated to drive the growth of the sleeping aid market in the coming years. An aging population refers to changes in a demographic's age distribution that result in a larger proportion of elderly individuals. As people age, various age-related factors can lead to sleep disorders and disturbances, heightening the demand for sleep-related solutions. For example, in May 2024, the Administration for Community Living, a U.S.-based government agency, reported that in 2022, 17.3% of the population was aged 65 or older, with projections indicating that this figure will rise to 22% by 2040. Thus, the growing global aging population is a significant driver of the sleeping aid market.

A notable trend in the sleeping aids market is the emphasis on product innovations by major market players. The development of new products, including wearable sleep aids, serves as a strategic approach for market players to maintain their competitive edge. In March 2022, StimScience, a US-based company specializing in sleeping aids, introduced Somnee, a wearable sleep aid. This innovative product stands out as the first electronic sleep aid headband featuring personalized non-invasive brain stimulation. Results from a 1,500-night home pilot study indicate a remarkable improvement in sleep quality and a reduction of over one-third in overnight tossing and turning. This exemplifies the industry's commitment to advancing solutions and meeting evolving consumer needs through innovative product offerings in the sleeping aids market.

Major players in the sleeping aids manufacturing sector are actively engaging in strategic collaborations with prominent manufacturing companies, a move aimed at fortifying their market positions. Strategic collaborations provide companies with the opportunity to join forces with partners possessing the requisite expertise to translate conceptual ideas into tangible solutions. In October 2023, EnsoData, Inc., a leading US-based software company specializing in artificial intelligence (AI) solutions for sleep testing, diagnosis, and treatment, revealed a strategic partnership with React Health, a US-based manufacturer of sleep and respiratory devices. The collaboration is designed to enhance Positive Airway Pressure (PAP) adherence support for patients with sleep apnea. By leveraging actionable data, durable medical equipment suppliers, and referring doctors will have the means to provide prompt and personalized support to patients facing challenges in adhering to their treatment plans. This strategic partnership exemplifies a concerted effort to optimize patient care through innovative collaborations within the sleeping aids market.

In August 2022, ResMed Inc., a prominent US-based company focused on the treatment of sleep apnea, chronic obstructive pulmonary disease, and other respiratory conditions, executed the acquisition of Mementor for an undisclosed amount. The acquisition underscores ResMed's commitment to digital health applications as an alternative to traditional pharmacological therapy, with the overarching goal of improving sleep quality. Mementor, a Germany-based consumer software developer specializing in sleep medicine, adds valuable capabilities to ResMed's portfolio, showcasing the company's dedication to expanding its offerings and staying at the forefront of advancements in sleep-related technologies. This strategic move exemplifies the industry's recognition of the importance of digital solutions in addressing sleep-related challenges and aligning with evolving consumer preferences.

Major companies operating in the sleeping aids market are Cadwell Industries Inc., Compumedics Limited, DeVilbiss Healthcare Pvt. Ltd., Merck & Co. Inc., Natus Medical Incorporated, Novartis AG, Pfizer Inc., Sanofi SA, Sleepmed Inc., Eisai Co. Ltd., ResMed Inc., Fisher & Paykel Healthcare Corporation Limited, Braebon Medical Corporation, Lowenstein Medical GmbH & Co. KG, Takeda Pharmaceutical Company Limited, Koninklijke Philips N.V., AstraZeneca PLC, Apnea Sciences Corp., Boehringer Ingelheim International GmbH, Teva Pharmaceutical Industries Ltd., Vanda Pharmaceuticals Inc., Cadila Healthcare Limited, Johnson & Johnson Services Inc., BMC Medical Co. Ltd., Cleveland Medical Devices Inc., Serta Simmons Bedding LLC, Tempur Sealy International Inc., Sleep Number Corporation, Casper Sleep Inc., Purple Innovation Inc., Leesa Sleep LLC

North America was the largest region in the sleeping aids market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the sleeping aids market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the sleeping aids market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The sleeping aids market consists of sales of insomnia treatment drugs, quazepam, narcolepsy treatment drugs, modafinil, and sodium oxybate. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Sleeping Aids Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on sleeping aids market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for sleeping aids ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The sleeping aids market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Sleeping Aids Market Characteristics

3. Sleeping Aids Market Trends And Strategies

4. Sleeping Aids Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Sleeping Aids Growth Analysis And Strategic Analysis Framework

6. Sleeping Aids Market Segmentation

7. Sleeping Aids Market Regional And Country Analysis

8. Asia-Pacific Sleeping Aids Market

9. China Sleeping Aids Market

10. India Sleeping Aids Market

11. Japan Sleeping Aids Market

12. Australia Sleeping Aids Market

13. Indonesia Sleeping Aids Market

14. South Korea Sleeping Aids Market

15. Western Europe Sleeping Aids Market

16. UK Sleeping Aids Market

17. Germany Sleeping Aids Market

18. France Sleeping Aids Market

19. Italy Sleeping Aids Market

20. Spain Sleeping Aids Market

21. Eastern Europe Sleeping Aids Market

22. Russia Sleeping Aids Market

23. North America Sleeping Aids Market

24. USA Sleeping Aids Market

25. Canada Sleeping Aids Market

26. South America Sleeping Aids Market

27. Brazil Sleeping Aids Market

28. Middle East Sleeping Aids Market

29. Africa Sleeping Aids Market

30. Sleeping Aids Market Competitive Landscape And Company Profiles

31. Sleeping Aids Market Other Major And Innovative Companies

32. Global Sleeping Aids Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Sleeping Aids Market

34. Recent Developments In The Sleeping Aids Market

35. Sleeping Aids Market High Potential Countries, Segments and Strategies

36. Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â